Alnylam Pharmaceuticals Inc (ALNY) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering ALNY.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
ALNY Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- The number of analysts covering the stock of ALNY is higher than 95.88% of all US stocks.
- ALNY has a higher average analyst price target than 96.04% of Pharmaceutical Products stocks.
- Alnylam Pharmaceuticals Inc's variance in analysts' estimates is lower than 10.12% of all US stocks.
- ALNY has a higher upside potential (average analyst target price relative to current price) than 15.09% of Pharmaceutical Products stocks.
- Alnylam Pharmaceuticals Inc's percent of analysts bearish on the stock is lower than almost 100% of all US stocks.
- The percentage of analysts bullish on the stock of ALNY is higher than practically none of all US stocks.
- ALNY has a less change in bullishness amongst analysts than almost 100% of all US stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Alnylam Pharmaceuticals Inc are SRPT, BMRN and RARE.
Make investment decisions regarding ALNY using the data that counts. Try POWR Ratings for free.